Clinical Trial Update: A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing mefloquine with sulfadoxine-pyrimethamine as malaria prophylaxis in pregnant HIV-positive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Fansidar (sulfadoxine-pyrimethamine)
• Mefloquine (Mefloquine)

Snippet

Sponsor: ORIYOMI OMOTOYOSI AKINYOTU | Conditions: Malaria in Pregnant HIV + Patients | Phase 1 | Status: COMPLETED